.png)
.png)
Report Library
View More
Datamonitor Healthcare Oncology: Ga...
July 29, 2021
Datamonitor Healthcare Oncology: Ut...
July 27, 2021
Datamonitor Healthcare CV&Met: Lyso...
July 26, 2021
Datamonitor Healthcare Oncology: NH...
July 26, 2021
Datamonitor Healthcare Other: Uteri...
July 26, 2021
Datamonitor Healthcare CV&Met: Atri...
July 23, 2021
Datamonitor Healthcare Oncology: NH...
July 23, 2021
Datamonitor Healthcare CNS: Eating ...
July 23, 2021
Datamonitor Healthcare Oncology Dis...
July 22, 2021
Datamonitor Healthcare I&I: Heredit...
July 22, 2021
Impact Events
More| Date | Lead Company |
Event | Type | Approval Change |
Approval Likelihood |
|---|---|---|---|---|---|
| 7/28/21 | Bristol Myers Squibb (BMY) | Opdivo for Esophageal Cancer | Subscribers Only | Subscribers Only | Subscribers Only |
| 7/28/21 | NewAmsterdam | Obicetrapib for Dyslipidemia / Hypercholesterolemia | Subscribers Only | Subscribers Only | Subscribers Only |
| 7/21/21 | Aprea (APRE) | Eprenetapopt for Myelodysplastic Syndrome (MDS) | Subscribers Only | Subscribers Only | Subscribers Only |
| 7/21/21 | Aprea (APRE) | Eprenetapopt for Acute Myelogenous Leukemia (AML) | Subscribers Only | Subscribers Only | Subscribers Only |
| 7/20/21 | Vericel Corporation (VCEL) | NexoBrid for Burn Injury | Subscribers Only | Subscribers Only | Subscribers Only |
Upcoming Catalysts
More| Expected Date Range |
Lead Company |
Drug | Expected Catalyst |
|---|---|---|---|
| 08/16/19 | Subscribers Only | Subscribers Only | Partnership - Acquisition Completion |
| 06/30/21 | Subscribers Only | Subscribers Only | Partnership - Acquisition Completion |
| 07/28/21 | Subscribers Only | Subscribers Only | Company - Analyst/R&D Update |
| 07/29/21 | Subscribers Only | Subscribers Only | Trial Data - Top-Line Results |
| 07/29/21 | Subscribers Only | Subscribers Only | Regulatory - PDUFA/Approval Decision (US) |
